Organisation paid for research Program year 2025 Source: CMS Open Payments

Carolina Eyecare Physicians, LLC

Neither a doctor nor a teaching hospital

Research payments

$1,218,178

869 payments

Through program year 2025, Carolina Eyecare Physicians, LLC is reported as receiving $1,218,178 in research payments, across 869 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$29,790	810
2024	Research	$186,793	3
2023	Research	$351,941	16
2022	Research	$276,368	19
2021	Research	$64,613	1
2020	Research	$173,069	14
2019	Research	$135,605	6

Breakdown

Who paid Research payments · program years 2019–2025

Johnson & Johnson Surgical Vision, Inc. $1,149,613 47 payments
NotalVision $29,790 810 payments
RxSight Inc $28,945 4 payments
Glaukos Corporation $9,830 8 payments

Studies the money was for Research payments · program years 2019–2025

Visual Performance and Patient Satisfaction with a New Monofocal Intraocular Lens $317,091 7 payments
Clinical Investigation of the TECNIS Next-Generation Intraocular Lens, Model DEN00V $266,545 11 payments
Evaluation of the Symfony with OptiBlue Intraocular Lens Compared to the Vivity IOL Under Mesopic Conditions $250,304 5 payments
Clinical investigation of the safety and effectiveness of a investigational model of the Tecnis Intraocular lens $121,300 10 payments
Visual outcomes in an extended depth of focus (EDOF) intraocular lens (IOL) $60,006 3 payments
Phase IV Study $52,690 1 payment
Clinical Comparison of Contrast Sensitivity Measures in the Pseudophakic Population $52,500 3 payments
Nrich $29,790 810 payments
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $28,945 4 payments
Visual outcomes of an extended depth of focus intraocular lens combined with a multifocal IOL $13,763 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.